HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Alaunos Therapeutics (NASDAQ:TCRT) from Neutral to Buy and announces $1.5 price target.
- Headlines
- HC Wainwright & Co. Upgrades Alaunos Therapeutics to Buy, Announces $1.5 Price Target
HC Wainwright & Co. Upgrades Alaunos Therapeutics to Buy, Announces $1.5 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Price
Log In for the Full List
Latest
23:31
The yield curve of the USA 2/10-year government bonds has reached its lowest level since the end of December last year, currently at 29.2 basis points.
23:29
The USA Senate Finance Committee voted to approve the nomination of Scott Bensent as Treasury Secretary under Trump and submitted the nomination for consideration by the full Senate.
23:23
Economists: The implementation of actual tariff policies remains highly uncertain.